Immunomedics Up 5% After Announcing Its New Studies About Development Of Cancer Products

April 14, 2014

Immunomedics Up 5% After Announcing Its New Studies About Development Of Cancer Products.

Tags epithelial cancer, IMMU, IMMU-130, IMMU-132, Immunomedics, metastatic colorectal cancer, pre-clinical trials, small-cell lung cancer, SN-38-containing antibody drug, triple-negative breast cancer

Top